Propanc Biopharma Q4 EPS $(0.10)

Benzinga Newsdesk www.benzinga.com Negative 97.0%

Neg 97% Neu 0% Pos 0%

Propanc Biopharma (NASDAQ:PPCB) reported quarterly losses of $(0.10) per share.

Comments

No comments yet. Be the first!